Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.

Johler, Sarah Maria; Fuchs, Jörg; Seitz, Guido; Armeanu-Ebinger, Sorin

Johler, Sarah Maria; Fuchs, Jörg; Seitz, Guido; Armeanu-Ebinger, Sorin.

Afiliação

Johler SM; Department of Pediatric Surgery and Urology, University Children's Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany.
Fuchs J; Department of Pediatric Surgery and Urology, University Children's Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany.
Seitz G; Department of Pediatric Surgery and Urology, University Children's Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany.
Armeanu-Ebinger S; Department of Pediatric Surgery and Urology, University Children's Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany. armeanu@uni-tuebingen.de.

Cancer Immunol Immunother ; 65(12): 1465-1476, 2016 12.

Article em En | MEDLINE | ID: mdl-27629595

Assuntos

Antineoplásicos/uso terapêutico; Imunoterapia/métodos; Fatores Inibidores da Migração de Macrófagos/uso terapêutico; Rabdomiossarcoma/terapia; Antineoplásicos/administração & dosagem; Antineoplásicos/farmacologia; Humanos; Fatores Inibidores da Migração de Macrófagos/administração & dosagem; Fatores Inibidores da Migração de Macrófagos/farmacologia

Palavras-chave

Immune escape and surveillance; Immunotherapy; MDSCs; MIF inhibitors; Macrophage migration inhibitory factor (MIF); Rhabdomyosarcoma

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Fatores Inibidores da Migração de Macrófagos / Imunoterapia / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links